Global Prostaglandin E2 Receptor EP2 Subtype Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 83194
  • calendar_today Published On: Apr, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Prostaglandin E2 Receptor EP2 Subtype market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Prostaglandin E2 Receptor EP2 Subtype size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Prostaglandin E2 Receptor EP2 Subtype market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Prostaglandin E2 Receptor EP2 Subtype market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

TG-4155

SAR-366234

ONO-8055

Treprostinil

Others

Market segment by Application, can be divided into

Clinic

Hospital

Others

Market segment by players, this report covers

Amgen Inc.

Ascendis Pharma A/S

Ono Pharmaceutical Co., Ltd.

Sanofi

Santen Pharmaceutical Co., Ltd.

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Prostaglandin E2 Receptor EP2 Subtype product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Prostaglandin E2 Receptor EP2 Subtype, with revenue, gross margin and global market share of Prostaglandin E2 Receptor EP2 Subtype from 2019 to 2021.

Chapter 3, the Prostaglandin E2 Receptor EP2 Subtype competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Prostaglandin E2 Receptor EP2 Subtype market forecast, by regions, type and application, with revenue, from 2021 to 2026.

Chapter 11 and 12, to describe Prostaglandin E2 Receptor EP2 Subtype research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Prostaglandin E2 Receptor EP2 Subtype

1.2 Classification of Prostaglandin E2 Receptor EP2 Subtype by Type

1.2.1 Overview: Global Prostaglandin E2 Receptor EP2 Subtype Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Type in 2020

1.2.3 TG-4155

1.2.4 SAR-366234

1.2.5 ONO-8055

1.2.6 Treprostinil

1.2.7 Others

1.3 Global Prostaglandin E2 Receptor EP2 Subtype Market by Application

1.3.1 Overview: Global Prostaglandin E2 Receptor EP2 Subtype Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Clinic

1.3.3 Hospital

1.3.4 Others

1.4 Global Prostaglandin E2 Receptor EP2 Subtype Market Size & Forecast

1.5 Global Prostaglandin E2 Receptor EP2 Subtype Market Size and Forecast by Region

1.5.1 Global Prostaglandin E2 Receptor EP2 Subtype Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Prostaglandin E2 Receptor EP2 Subtype Market Size by Region, (2016-2021)

1.5.3 North America Prostaglandin E2 Receptor EP2 Subtype Market Size and Prospect (2016-2026)

1.5.4 Europe Prostaglandin E2 Receptor EP2 Subtype Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Prostaglandin E2 Receptor EP2 Subtype Market Size and Prospect (2016-2026)

1.5.6 South America Prostaglandin E2 Receptor EP2 Subtype Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Prostaglandin E2 Receptor EP2 Subtype Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Prostaglandin E2 Receptor EP2 Subtype Market Drivers

1.6.2 Prostaglandin E2 Receptor EP2 Subtype Market Restraints

1.6.3 Prostaglandin E2 Receptor EP2 Subtype Trends Analysis

2 Company Profiles

2.1 Amgen Inc.

2.1.1 Amgen Inc. Details

2.1.2 Amgen Inc. Major Business

2.1.3 Amgen Inc. Prostaglandin E2 Receptor EP2 Subtype Product and Solutions

2.1.4 Amgen Inc. Prostaglandin E2 Receptor EP2 Subtype Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Amgen Inc. Recent Developments and Future Plans

2.2 Ascendis Pharma A/S

2.2.1 Ascendis Pharma A/S Details

2.2.2 Ascendis Pharma A/S Major Business

2.2.3 Ascendis Pharma A/S Prostaglandin E2 Receptor EP2 Subtype Product and Solutions

2.2.4 Ascendis Pharma A/S Prostaglandin E2 Receptor EP2 Subtype Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Ascendis Pharma A/S Recent Developments and Future Plans

2.3 Ono Pharmaceutical Co., Ltd.

2.3.1 Ono Pharmaceutical Co., Ltd. Details

2.3.2 Ono Pharmaceutical Co., Ltd. Major Business

2.3.3 Ono Pharmaceutical Co., Ltd. Prostaglandin E2 Receptor EP2 Subtype Product and Solutions

2.3.4 Ono Pharmaceutical Co., Ltd. Prostaglandin E2 Receptor EP2 Subtype Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Ono Pharmaceutical Co., Ltd. Recent Developments and Future Plans

2.4 Sanofi

2.4.1 Sanofi Details

2.4.2 Sanofi Major Business

2.4.3 Sanofi Prostaglandin E2 Receptor EP2 Subtype Product and Solutions

2.4.4 Sanofi Prostaglandin E2 Receptor EP2 Subtype Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Sanofi Recent Developments and Future Plans

2.5 Santen Pharmaceutical Co., Ltd.

2.5.1 Santen Pharmaceutical Co., Ltd. Details

2.5.2 Santen Pharmaceutical Co., Ltd. Major Business

2.5.3 Santen Pharmaceutical Co., Ltd. Prostaglandin E2 Receptor EP2 Subtype Product and Solutions

2.5.4 Santen Pharmaceutical Co., Ltd. Prostaglandin E2 Receptor EP2 Subtype Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Santen Pharmaceutical Co., Ltd. Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Prostaglandin E2 Receptor EP2 Subtype Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Prostaglandin E2 Receptor EP2 Subtype Players Market Share

3.2.2 Top 10 Prostaglandin E2 Receptor EP2 Subtype Players Market Share

3.2.3 Market Competition Trend

3.3 Prostaglandin E2 Receptor EP2 Subtype Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Prostaglandin E2 Receptor EP2 Subtype Revenue and Market Share by Type (2016-2021)

4.2 Global Prostaglandin E2 Receptor EP2 Subtype Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Application (2016-2021)

5.2 Prostaglandin E2 Receptor EP2 Subtype Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2016-2026)

6.2 North America Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2016-2026)

6.3 North America Prostaglandin E2 Receptor EP2 Subtype Market Size by Country

6.3.1 North America Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2016-2026)

6.3.2 United States Prostaglandin E2 Receptor EP2 Subtype Market Size and Forecast (2016-2026)

6.3.3 Canada Prostaglandin E2 Receptor EP2 Subtype Market Size and Forecast (2016-2026)

6.3.4 Mexico Prostaglandin E2 Receptor EP2 Subtype Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2016-2026)

7.2 Europe Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2016-2026)

7.3 Europe Prostaglandin E2 Receptor EP2 Subtype Market Size by Country

7.3.1 Europe Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2016-2026)

7.3.2 Germany Prostaglandin E2 Receptor EP2 Subtype Market Size and Forecast (2016-2026)

7.3.3 France Prostaglandin E2 Receptor EP2 Subtype Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Prostaglandin E2 Receptor EP2 Subtype Market Size and Forecast (2016-2026)

7.3.5 Russia Prostaglandin E2 Receptor EP2 Subtype Market Size and Forecast (2016-2026)

7.3.6 Italy Prostaglandin E2 Receptor EP2 Subtype Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2016-2026)

8.2 Asia-Pacific Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2016-2026)

8.3 Asia-Pacific Prostaglandin E2 Receptor EP2 Subtype Market Size by Region

8.3.1 Asia-Pacific Prostaglandin E2 Receptor EP2 Subtype Revenue by Region (2016-2026)

8.3.2 China Prostaglandin E2 Receptor EP2 Subtype Market Size and Forecast (2016-2026)

8.3.3 Japan Prostaglandin E2 Receptor EP2 Subtype Market Size and Forecast (2016-2026)

8.3.4 South Korea Prostaglandin E2 Receptor EP2 Subtype Market Size and Forecast (2016-2026)

8.3.5 India Prostaglandin E2 Receptor EP2 Subtype Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Prostaglandin E2 Receptor EP2 Subtype Market Size and Forecast (2016-2026)

8.3.7 Australia Prostaglandin E2 Receptor EP2 Subtype Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2016-2026)

9.2 South America Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2016-2026)

9.3 South America Prostaglandin E2 Receptor EP2 Subtype Market Size by Country

9.3.1 South America Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2016-2026)

9.3.2 Brazil Prostaglandin E2 Receptor EP2 Subtype Market Size and Forecast (2016-2026)

9.3.3 Argentina Prostaglandin E2 Receptor EP2 Subtype Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2016-2026)

10.2 Middle East & Africa Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2016-2026)

10.3 Middle East & Africa Prostaglandin E2 Receptor EP2 Subtype Market Size by Country

10.3.1 Middle East & Africa Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2016-2026)

10.3.2 Turkey Prostaglandin E2 Receptor EP2 Subtype Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Prostaglandin E2 Receptor EP2 Subtype Market Size and Forecast (2016-2026)

10.3.4 UAE Prostaglandin E2 Receptor EP2 Subtype Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Prostaglandin E2 Receptor EP2 Subtype Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Prostaglandin E2 Receptor EP2 Subtype Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Prostaglandin E2 Receptor EP2 Subtype Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Prostaglandin E2 Receptor EP2 Subtype Revenue (USD Million) by Region (2016-2021)

Table 5. Global Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Region (2021-2026)

Table 6. Amgen Inc. Corporate Information, Head Office, and Major Competitors

Table 7. Amgen Inc. Major Business

Table 8. Amgen Inc. Prostaglandin E2 Receptor EP2 Subtype Product and Solutions

Table 9. Amgen Inc. Prostaglandin E2 Receptor EP2 Subtype Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Ascendis Pharma A/S Corporate Information, Head Office, and Major Competitors

Table 11. Ascendis Pharma A/S Major Business

Table 12. Ascendis Pharma A/S Prostaglandin E2 Receptor EP2 Subtype Product and Solutions

Table 13. Ascendis Pharma A/S Prostaglandin E2 Receptor EP2 Subtype Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Ono Pharmaceutical Co., Ltd. Corporate Information, Head Office, and Major Competitors

Table 15. Ono Pharmaceutical Co., Ltd. Major Business

Table 16. Ono Pharmaceutical Co., Ltd. Prostaglandin E2 Receptor EP2 Subtype Product and Solutions

Table 17. Ono Pharmaceutical Co., Ltd. Prostaglandin E2 Receptor EP2 Subtype Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Sanofi Corporate Information, Head Office, and Major Competitors

Table 19. Sanofi Major Business

Table 20. Sanofi Prostaglandin E2 Receptor EP2 Subtype Product and Solutions

Table 21. Sanofi Prostaglandin E2 Receptor EP2 Subtype Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Santen Pharmaceutical Co., Ltd. Corporate Information, Head Office, and Major Competitors

Table 23. Santen Pharmaceutical Co., Ltd. Major Business

Table 24. Santen Pharmaceutical Co., Ltd. Prostaglandin E2 Receptor EP2 Subtype Product and Solutions

Table 25. Santen Pharmaceutical Co., Ltd. Prostaglandin E2 Receptor EP2 Subtype Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Global Prostaglandin E2 Receptor EP2 Subtype Revenue (USD Million) by Players (2019-2021)

Table 27. Global Prostaglandin E2 Receptor EP2 Subtype Revenue Share by Players (2019-2021)

Table 28. Breakdown of Prostaglandin E2 Receptor EP2 Subtype by Company Type (Tier 1, Tier 2 and Tier 3)

Table 29. Prostaglandin E2 Receptor EP2 Subtype Players Head Office, Products and Services Provided

Table 30. Prostaglandin E2 Receptor EP2 Subtype Mergers & Acquisitions in the Past Five Years

Table 31. Prostaglandin E2 Receptor EP2 Subtype New Entrants and Expansion Plans

Table 32. Global Prostaglandin E2 Receptor EP2 Subtype Revenue (USD Million) by Type (2016-2021)

Table 33. Global Prostaglandin E2 Receptor EP2 Subtype Revenue Share by Type (2016-2021)

Table 34. Global Prostaglandin E2 Receptor EP2 Subtype Revenue Forecast by Type (2021-2026)

Table 35. Global Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2016-2021)

Table 36. Global Prostaglandin E2 Receptor EP2 Subtype Revenue Forecast by Application (2021-2026)

Table 37. North America Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2016-2021) & (USD Million)

Table 38. North America Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2021-2026) & (USD Million)

Table 39. North America Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2016-2021) & (USD Million)

Table 40. North America Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2021-2026) & (USD Million)

Table 41. North America Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2016-2021) & (USD Million)

Table 42. North America Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2021-2026) & (USD Million)

Table 43. Europe Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2016-2021) & (USD Million)

Table 44. Europe Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2021-2026) & (USD Million)

Table 45. Europe Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2016-2021) & (USD Million)

Table 46. Europe Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2021-2026) & (USD Million)

Table 47. Europe Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2016-2021) & (USD Million)

Table 48. Europe Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2021-2026) & (USD Million)

Table 49. Asia-Pacific Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2016-2021) & (USD Million)

Table 50. Asia-Pacific Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2021-2026) & (USD Million)

Table 51. Asia-Pacific Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2016-2021) & (USD Million)

Table 52. Asia-Pacific Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2021-2026) & (USD Million)

Table 53. Asia-Pacific Prostaglandin E2 Receptor EP2 Subtype Revenue by Region (2016-2021) & (USD Million)

Table 54. Asia-Pacific Prostaglandin E2 Receptor EP2 Subtype Revenue by Region (2021-2026) & (USD Million)

Table 55. South America Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2016-2021) & (USD Million)

Table 56. South America Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2021-2026) & (USD Million)

Table 57. South America Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2016-2021) & (USD Million)

Table 58. South America Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2021-2026) & (USD Million)

Table 59. South America Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2016-2021) & (USD Million)

Table 60. South America Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2021-2026) & (USD Million)

Table 61. Middle East & Africa Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2016-2021) & (USD Million)

Table 62. Middle East & Africa Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2021-2026) & (USD Million)

Table 63. Middle East & Africa Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2016-2021) & (USD Million)

Table 64. Middle East & Africa Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2021-2026) & (USD Million)

Table 65. Middle East & Africa Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2016-2021) & (USD Million)

Table 66. Middle East & Africa Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Prostaglandin E2 Receptor EP2 Subtype Picture

Figure 2. Global Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Type in 2020

Figure 3. TG-4155

Figure 4. SAR-366234

Figure 5. ONO-8055

Figure 6. Treprostinil

Figure 7. Others

Figure 8. Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Application in 2020

Figure 9. Clinic Picture

Figure 10. Hospital Picture

Figure 11. Others Picture

Figure 12. Global Prostaglandin E2 Receptor EP2 Subtype Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 13. Global Prostaglandin E2 Receptor EP2 Subtype Revenue and Forecast (2016-2026) & (USD Million)

Figure 14. Global Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Region (2016-2026)

Figure 15. Global Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Region in 2020

Figure 16. North America Prostaglandin E2 Receptor EP2 Subtype Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Europe Prostaglandin E2 Receptor EP2 Subtype Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Asia-Pacific Prostaglandin E2 Receptor EP2 Subtype Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. South America Prostaglandin E2 Receptor EP2 Subtype Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Middle East and Africa Prostaglandin E2 Receptor EP2 Subtype Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. Prostaglandin E2 Receptor EP2 Subtype Market Drivers

Figure 22. Prostaglandin E2 Receptor EP2 Subtype Market Restraints

Figure 23. Prostaglandin E2 Receptor EP2 Subtype Market Trends

Figure 24. Amgen Inc. Recent Developments and Future Plans

Figure 25. Ascendis Pharma A/S Recent Developments and Future Plans

Figure 26. Ono Pharmaceutical Co., Ltd. Recent Developments and Future Plans

Figure 27. Sanofi Recent Developments and Future Plans

Figure 28. Santen Pharmaceutical Co., Ltd. Recent Developments and Future Plans

Figure 29. Global Prostaglandin E2 Receptor EP2 Subtype Revenue Share by Players in 2020

Figure 30. Prostaglandin E2 Receptor EP2 Subtype Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 31. Global Top 3 Players Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share in 2020

Figure 32. Global Top 10 Players Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share in 2020

Figure 33. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 34. Global Prostaglandin E2 Receptor EP2 Subtype Revenue Share by Type in 2020

Figure 35. Global Prostaglandin E2 Receptor EP2 Subtype Market Share Forecast by Type (2021-2026)

Figure 36. Global Prostaglandin E2 Receptor EP2 Subtype Revenue Share by Application in 2020

Figure 37. Global Prostaglandin E2 Receptor EP2 Subtype Market Share Forecast by Application (2021-2026)

Figure 38. North America Prostaglandin E2 Receptor EP2 Subtype Sales Market Share by Type (2016-2026)

Figure 39. North America Prostaglandin E2 Receptor EP2 Subtype Sales Market Share by Application (2016-2026)

Figure 40. North America Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Country (2016-2026)

Figure 41. United States Prostaglandin E2 Receptor EP2 Subtype Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 42. Canada Prostaglandin E2 Receptor EP2 Subtype Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 43. Mexico Prostaglandin E2 Receptor EP2 Subtype Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 44. Europe Prostaglandin E2 Receptor EP2 Subtype Sales Market Share by Type (2016-2026)

Figure 45. Europe Prostaglandin E2 Receptor EP2 Subtype Sales Market Share by Application (2016-2026)

Figure 46. Europe Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Country (2016-2026)

Figure 47. Germany Prostaglandin E2 Receptor EP2 Subtype Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 48. France Prostaglandin E2 Receptor EP2 Subtype Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. United Kingdom Prostaglandin E2 Receptor EP2 Subtype Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Russia Prostaglandin E2 Receptor EP2 Subtype Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Italy Prostaglandin E2 Receptor EP2 Subtype Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. Asia-Pacific Prostaglandin E2 Receptor EP2 Subtype Sales Market Share by Type (2016-2026)

Figure 53. Asia-Pacific Prostaglandin E2 Receptor EP2 Subtype Sales Market Share by Application (2016-2026)

Figure 54. Asia-Pacific Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Region (2016-2026)

Figure 55. China Prostaglandin E2 Receptor EP2 Subtype Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Japan Prostaglandin E2 Receptor EP2 Subtype Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. South Korea Prostaglandin E2 Receptor EP2 Subtype Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. India Prostaglandin E2 Receptor EP2 Subtype Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Southeast Asia Prostaglandin E2 Receptor EP2 Subtype Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Australia Prostaglandin E2 Receptor EP2 Subtype Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. South America Prostaglandin E2 Receptor EP2 Subtype Sales Market Share by Type (2016-2026)

Figure 62. South America Prostaglandin E2 Receptor EP2 Subtype Sales Market Share by Application (2016-2026)

Figure 63. South America Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Country (2016-2026)

Figure 64. Brazil Prostaglandin E2 Receptor EP2 Subtype Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. Argentina Prostaglandin E2 Receptor EP2 Subtype Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Middle East and Africa Prostaglandin E2 Receptor EP2 Subtype Sales Market Share by Type (2016-2026)

Figure 67. Middle East and Africa Prostaglandin E2 Receptor EP2 Subtype Sales Market Share by Application (2016-2026)

Figure 68. Middle East and Africa Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Country (2016-2026)

Figure 69. Turkey Prostaglandin E2 Receptor EP2 Subtype Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. Saudi Arabia Prostaglandin E2 Receptor EP2 Subtype Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. UAE Prostaglandin E2 Receptor EP2 Subtype Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Methodology

Figure 73. Research Process and Data Source